Feng Mei

ORCID: 0009-0004-1032-0988
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Inflammatory Biomarkers in Disease Prognosis
  • Retinal Diseases and Treatments
  • Retinal Imaging and Analysis
  • Bone and Joint Diseases
  • Ophthalmology and Visual Impairment Studies
  • Molecular Sensors and Ion Detection
  • Medical Research and Treatments
  • Luminescence and Fluorescent Materials
  • Photopolymerization techniques and applications
  • Analytical Chemistry and Sensors
  • Advanced biosensing and bioanalysis techniques
  • Conducting polymers and applications
  • Neurological Disease Mechanisms and Treatments
  • Ginseng Biological Effects and Applications
  • Proteoglycans and glycosaminoglycans research
  • Corneal surgery and disorders
  • Neurological Disorders and Treatments
  • Regulation of Appetite and Obesity
  • Erythropoietin and Anemia Treatment
  • Glaucoma and retinal disorders
  • Acute Ischemic Stroke Management
  • Adipokines, Inflammation, and Metabolic Diseases

Anhui Provincial Hospital
2023

Guangdong Provincial Hospital of Traditional Chinese Medicine
2020

Nanchang University
2019

First Affiliated Hospital of Nanchang University
2019

Jiangxi Provincial People's Hospital
2019

Soochow University
2018

Background. This study is aimed at investigating the relationship between neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte (PLR), and hyperhomocysteinemia (HHCY) in patients with ischemic stroke (IS). Methods. retrospectively analyzed clinical data laboratory results of 110 IS patients. According to cut-off value <math xmlns="http://www.w3.org/1998/Math/MathML" id="M1"> <mtext>HCY</mtext> <mo>=</mo> <mn>15</mn> <mtext> </mtext> <mi>μ</mi> <mtext>mol</mtext> <mo>/</mo>...

10.1155/2023/6642768 article EN Acta Neurologica Scandinavica 2023-09-19

The anemia of chronic disease is infection, inflammation, a class cancer-related syndrome, in patients with malignant tumors often. In recent years recombinant human erythropoietin, widely used clinical treatment anemia, Especially achieved remarkable results, blood transfusion to avoid the many adverse effects and improve patient' s quality life. A control chemotherapy-induced an important choice. Therefore, rhEPO on mechanism has also become research hotspot. Key words:...

10.3760/cma.j.issn.1009-9921.2008.03.026 article EN 白血病·淋巴瘤 2008-06-25

Abstract Background: To investigate the prognostic value of neutrophil-to-lymphocyte ratio (NLR) in patients with diabetic macular edema (DME) treated monthly ranibizumab. Methods: We retrospectively analyzed medical records all who received intravitreal ranibizumab (IVR) treatment for DME at First Affiliated Hospital Nanchang University between December 2015 and 2017. Clinicopathological parameters, including NLR, were evaluated to identify predictors better outcomes IVR monotherapy....

10.21203/rs.2.9451/v1 preprint EN cc-by Research Square (Research Square) 2019-05-03

Abstract Background: To investigate the prognostic value of neutrophil-to-lymphocyte ratio (NLR) in patients with diabetic macular edema (DME) treated monthly ranibizumab. Methods: We retrospectively analyzed medical records all who received intravitreal ranibizumab (IVR) treatment for DME at First Affiliated Hospital Nanchang University between December 2015 and 2017. Clinicopathological parameters, including NLR, were evaluated to identify predictors better outcomes IVR monotherapy....

10.21203/rs.2.9451/v3 preprint EN cc-by Research Square (Research Square) 2019-10-11

Abstract Background: To investigate the prognostic value of neutrophil-to-lymphocyte ratio (NLR) in patients with diabetic macular edema (DME) treated monthly ranibizumab. Methods: We retrospectively analyzed medical records all who received intravitreal ranibizumab (IVR) treatment for DME at First Affiliated Hospital Nanchang University between December 2015 and 2017. Clinicopathological parameters, including NLR, were evaluated to identify predictors better outcomes IVR monotherapy....

10.21203/rs.2.9451/v2 preprint EN cc-by Research Square (Research Square) 2019-07-24
Coming Soon ...